1. Home
  2. VALN vs BIT Comparison

VALN vs BIT Comparison

Compare VALN & BIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • BIT
  • Stock Information
  • Founded
  • VALN 2012
  • BIT 2013
  • Country
  • VALN France
  • BIT United States
  • Employees
  • VALN N/A
  • BIT N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • BIT Trusts Except Educational Religious and Charitable
  • Sector
  • VALN Health Care
  • BIT Finance
  • Exchange
  • VALN Nasdaq
  • BIT Nasdaq
  • Market Cap
  • VALN 510.7M
  • BIT 599.5M
  • IPO Year
  • VALN 2021
  • BIT N/A
  • Fundamental
  • Price
  • VALN $6.40
  • BIT $14.23
  • Analyst Decision
  • VALN Strong Buy
  • BIT
  • Analyst Count
  • VALN 3
  • BIT 0
  • Target Price
  • VALN $15.33
  • BIT N/A
  • AVG Volume (30 Days)
  • VALN 83.3K
  • BIT 92.4K
  • Earning Date
  • VALN 05-07-2025
  • BIT 01-01-0001
  • Dividend Yield
  • VALN N/A
  • BIT 9.36%
  • EPS Growth
  • VALN N/A
  • BIT N/A
  • EPS
  • VALN N/A
  • BIT N/A
  • Revenue
  • VALN $201,099,222.00
  • BIT N/A
  • Revenue This Year
  • VALN $18.74
  • BIT N/A
  • Revenue Next Year
  • VALN $29.26
  • BIT N/A
  • P/E Ratio
  • VALN N/A
  • BIT N/A
  • Revenue Growth
  • VALN 21.64
  • BIT N/A
  • 52 Week Low
  • VALN $3.62
  • BIT $13.65
  • 52 Week High
  • VALN $9.50
  • BIT $15.97
  • Technical
  • Relative Strength Index (RSI)
  • VALN 48.49
  • BIT 52.08
  • Support Level
  • VALN $6.18
  • BIT $14.07
  • Resistance Level
  • VALN $6.54
  • BIT $14.37
  • Average True Range (ATR)
  • VALN 0.21
  • BIT 0.12
  • MACD
  • VALN 0.01
  • BIT -0.02
  • Stochastic Oscillator
  • VALN 54.35
  • BIT 32.65

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About BIT BlackRock Multi-Sector Income Trust of Beneficial Interest

BlackRock Multi-Sector Income Trust is a closed-end investment management company. It invests on behalf of its clients. The fund's primary investment objective is to provide a high level of current income, with a secondary objective of capital appreciation. The company seeks to achieve its investment objectives by investing, under normal market conditions, a majority of its assets in loan and debt instruments and other investments with similar economic characteristics. Its portfolio consists of Corporate Bonds, Asset-Backed Securities, Preferred Securities, and others.

Share on Social Networks: